Description
An orally bioavailable inhibitor of HIV-1 integrase (IC50 = 15 nM in a strand transfer assay); inhibits the spread of HIV-1IIIb infection in MT-4 cell culture (CIC95s = 19 and 31 nM in medium containing 10% heat-inactivated FBS or 50% normal human serum, respectively); is metabolized in the liver primarily by UGT1A1
Formal name: N-[(4-fluorophenyl)methyl]-1,6-dihydro-5-hydroxy-1-methyl-2-[1-methyl-1-[[(5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino]ethyl]-6-oxo-4-pyrimidinecarboxamide, monopotassium salt
Synonyms: MK-0518
Molecular weight: 482.5
CAS: 871038-72-1
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Antivirals|Integrase Inhibitors||Product Type|Biochemicals|Small Molecule Inhibitors|Nucleic Acid Turnover/Signaling||Research Area|Immunology & Inflammation||Research Area|Infectious Disease|Viral Diseases|HIV & AIDS